htu-520
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2011 (NCT01400594)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hts-519
- htu-520
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02798380 | Phase 2 | Jul 1, 2016 | Hallux, Inc. |
| NCT01400594 | Phase 2 | Jul 1, 2011 | Hisamitsu Pharmaceutical Co., Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hallux, Inc. | For profit | 1 | 1 | 1 | 2016 |
| Hisamitsu Pharmaceutical Co., Inc. | For profit | 1 | 1 | 1 | 2011 |
2 organizations
Page 1 / 1